颅脑损伤后患者血清神经元特异性烯醇化酶与S100B蛋白的动态性变化及意义

梁炯芳; 高峰平; 刘克洪

doi:10.16766/j.cnki.issn.1674-4152.001930

颅脑损伤后患者血清神经元特异性烯醇化酶与S100B蛋白的动态性变化及意义

doi: 10.16766/j.cnki.issn.1674-4152.001930

1.
武警浙江省总队医院检验科，浙江杭州 310000
2.
武警浙江省总队医院康复中心，浙江杭州 310000

基金项目:

浙江省医药卫生科技计划项目 2020KY776

详细信息

通讯作者:
梁炯芳，E-mail: 13175317645@163.com

中图分类号: R651.15 R446.6
计量
- 文章访问数: 238
- HTML全文浏览量: 109
- PDF下载量: 3
- 被引次数: 0
出版历程
- 收稿日期: 2020-05-22
- 网络出版日期: 2022-02-16

Dynamic changes and significance of serum NSE and S100B protein in patients with craniocerebral injury

1.
Department of Clinical Laboratory of Zhejiang General Hospital of Armed Police, Hangzhou, Zhejiang 310000, China

摘要

摘要: 目的探讨颅脑损伤后血清神经元特异性烯醇化酶(neuron-specific enolase，NSE)与S100B蛋白水平的动态性变化规律及临床意义。方法选取武警浙江省总队医院急诊科2018年1月—2019年12月接收的105例颅脑损伤患者为研究对象，按格拉斯哥评分分为轻度组(30例)、中度组(45例)和重度组(30例)，另选同期健康体检者30例作为对照组。动态监测并统计分析患者颅脑损伤后血清NSE与S100B蛋白数据。结果重度组、中度组、轻度组、对照组4组血清NSE与S100B蛋白水平分别为(34.51±5.39)μg/L、(19.31±2.72)μg/L、(13.68±3.02)μg/L、(6.11±2.35)μg/L与(2.29±0.28)μg/L、(1.47±0.15)μg/L、(0.81±0.18)μg/L、(0.32±0.09)μg/L，F=357.010，653.126，均P < 0.001；各组同时间点血清NSE与S100B蛋白比较差异有统计学意义(均P < 0.05)；血清NSE与S100B组间及组内不同时点两两比较差异均有统计学意义(均P < 0.05)。结论血清NSE与S100B蛋白水平能够动态性地反映急性颅脑损伤的病情进展，对病情分级修正、制定治疗方案及评估预后均有重要的临床指导意义。
- 颅脑损伤 /
- 神经元特异性烯醇化酶 /
- S100B蛋白 /
- 动态监测
Abstract: Objective To explore the dynamic changes and clinical significance of serum NSE and S100B protein levels after craniocerebral injury. Methods A total of 105 patients with craniocerebral injury received by the Emergency Department of Zhejiang General Hospital of Armed Police from January 2018 to December 2019 were selected as the study objects. According to Glasgow's score, they were divided into mild group (n=30), moderate group (n=45) and severe group (n=30). Another 30 healthy people in the same period were selected as the control group. Dynamic monitoring and statistical analysis of serum NSE and S100B protein data after head injury were conducted. Results The serum NSE and S100B protein levels among the four groups were (34.51±5.39) μg/L, (19.31±2.72) μg/L, (13.68±3.02) μg/L, (6.11±2.35) μg/L and (2.29±0.28) μg/L, (1.47±0.15) μg/L, (0.81±0.18) μg/L, (0.32±0.09) μg/L (F=357.010, 653.126, all P < 0.001)respectively. For each group at the same time, the difference in serum NSE and S100B protein was statistically significant (all P < 0.05). The differences in serum NSE and S100B between groups within the group and at different time points were statistically significant (all P < 0.05). Conclusion Serum NSE and S100B protein levels can dynamically reflect the progress of acute craniocerebral injury a which have important clinical guiding significance for the revision of the disease disease classification, formulation of treatment plans assessment of prognosis.
- Craniocerebral injury /
- Neuron-specific enolase /
- S100B protein /
- Dynamic Monitoring

HTML全文

表 1 4组血清NSE与S100B蛋白水平的比较(x±s，μg/L)

组别	例数	NSE	S100B蛋白
重度组	30	34.51±5.39^a	2.29±0.28^a
中度组	45	19.31±2.72^a	1.47±0.15^a
轻度组	30	13.68±3.02^a	0.81±0.18^a
对照组	30	6.11±2.35	0.32±0.09
F值		357.010	653.126
P值		< 0.001	< 0.001
注：与对照组比较，^aP < 0.05。

下载: 导出CSV

表 2 不同组别各时段血清NSE水平动态变化的比较(x±s，μg/L)

组别	例数	12 h	24 h	3 d	7 d	14 d	F值	P值
重度组	30	31.43±5.11^ab	34.51±5.39^ab	38.67±7.30^ab	27.79±6.39^ab	24.45±6.93^ab	23.539	< 0.001
中度组	45	17.27±2.55^a	19.31±2.72^a	17.05±2.23^a	12.65±1.20^a	9.71±0.88^a	163.355	< 0.001
轻度组	30	10.97±3.07	13.68±3.02	12.26±2.28	9.75±2.77	8.66±2.64	15.424	< 0.001
F值		258.599	252.666	327.130	183.673	154.814
P值		< 0.001	< 0.001	< 0.001	< 0.001	< 0.001
注：与轻度组比较，^aP < 0.05；与中度组比较，^bP < 0.05。

下载: 导出CSV

表 3 不同组别间各时点血清S100B蛋白水平动态变化的比较(x±s，μg/L)

组别	例数	12 h	24 h	3 d	7 d	14 d	F值	P值
重度组	30	2.07±0.23^ab	2.29±0.28^ab	1.88±0.19^ab	1.42±0.27^ab	1.04±0.15^ab	146.033	< 0.001
中度组	45	1.32±0.13^a	1.47±0.15^a	0.93±0.13^a	0.58±0.09	0.58±0.08^a	359.174	< 0.001
轻度组	30	0.71±0.14	0.81±0.18	0.66±0.17	0.49±0.15	0.44±0.14	28.988	< 0.001
F值		499.410	400.659	490.842	270.915	205.639
P值		< 0.001	< 0.001	< 0.001	< 0.001	< 0.001
注：与轻度组比较，^aP < 0.05；与中度组比较，^bP < 0.05。

下载: 导出CSV

参考文献(20)

[1]	莫海军, 丁燕晶, 李金庭, 等. 重型颅脑损伤患者血清高迁移率族蛋白B1、白细胞介素-1和白细胞介素-6、S100B的水平变化及临床意义[J]. 中国医药科学, 2018, 8(13): 191-193. doi: 10.3969/j.issn.2095-0616.2018.13.055
[2]	丁燕晶, 叶嘉辉, 莫海军, 等. 重型颅脑损伤患者血清高迁移率族蛋白B1、白细胞介素-1和白细胞介素-6、S100B蛋白的水平变化及临床意义[J]. 中国药物经济学, 2018, 13(5): 34-37. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYWA201805009.htm
[3]	叶嘉辉, 丁燕晶. 重型颅脑损伤患者血清白介素6、S100B与颅内压变化的相关性分析[J]. 包头医学院学报, 2019, 35(4): 5-7. https://www.cnki.com.cn/Article/CJFDTOTAL-BTYX201904003.htm
[4]	唐忠, 陈启富, 徐岩, 等. 重型颅脑损伤患者血清S100B和TNF-α变化研究[J]. 中国现代医生, 2016, 54(13): 16-18. https://www.cnki.com.cn/Article/CJFDTOTAL-ZDYS201613005.htm
[5]	周海航, 张李涛, 沈建国, 等. 重型颅脑损伤患者血清S100B、IL-6与颅压力变化的相关性研究[J]. 中华全科医学, 2017, 15(4): 574-576. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201704010.htm
[6]	李浩, 张磊. 小牛血清去蛋白注射液对急性脑梗死疗效、血清神经元特异性烯醇化酶和S100B蛋白影响观察[J]. 临床医药文献电子杂志, 2017, 4(76): 14866-14868. doi: 10.3877/j.issn.2095-8242.2017.76.008
[7]	张熙赟, 张熙燕, 余兆祥. 围术期颅内压监测指导治疗对重症颅脑损伤患者脑脊液BDNF、s100b蛋白水平的影响[J]. 江西医药, 2019, 54(8): 923-925. https://www.cnki.com.cn/Article/CJFDTOTAL-JXYY201908014.htm
[8]	谢凤欣, 张东云, 府伟灵, 等. 颅脑损伤生物标志物的研究现状与未来[J]. 中华全科医学, 2020, 18(4): 638-641. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY202004032.htm
[9]	余美红. S100B和NSE联合检测对颅脑损伤患者早期预后判断的应用价值[J]. 浙江创伤外科, 2019, 24(3): 571-572. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJCW201903073.htm
[10]	顾志伟, 屠传建, 宋大刚, 等. 血清NSE、S100B蛋白和颅脑损伤程度及预后的相关性研究[J]. 浙江创伤外科, 2019, 24(3): 524-526. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJCW201903048.htm
[11]	张振雨. 脊柱骨折伴急性脊髓损伤患者血清NSE、S100B蛋白水平变化及意义[J]. 颈腰痛杂志, 2019, 40(3): 332-334. https://www.cnki.com.cn/Article/CJFDTOTAL-JYTZ201903013.htm
[12]	孙广卫, 唐勇, 司马国忠. NSE、S100B及血流动力学变化在显微外科手术治疗颅内动脉瘤患者的预后分析[J]. 中华神经创伤外科电子杂志, 2019, 5(6): 336-340. https://www.cnki.com.cn/Article/CJFDTOTAL-SJCW201906004.htm
[13]	HAQUE A, RAY S K, COX A, et al. Neuron specific enolase: a promising therapeutic target in acute spinal cord injury[J]. Metabolic Brain Dis, 2016, 31(3): 1-9. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864119/pdf/nihms-757955.pdf
[14]	MERCIER E, TARDIF P A, CAMERON P A, et al. Prognostic value of neuron-specific enolase(NSE) for prediction of post-concussion symptoms following a mild traumatic brain injury: a systematic review[J]. Brain Injury, 2018, 32(1): 29-40. http://smartsearch.nstl.gov.cn/paper_detail.html?id=827812fcf094ee809e90da437a576605
[15]	MASSIMO M, MARINA C, CRISTINA M, et al. Integrated multiomics approach identifies calcium and integrin-bingding protein-2 as a novel gene for pulse wave velocity[J]. J Hypertens, 2016, 34(1): 79-87. http://d.wanfangdata.com.cn/periodical/ChlQZXJpb2RpY2FsRW5nTmV3UzIwMjEwMzAyEiAyNDE1Y2NiZWVlZWNmYTgzZWIzY2I5OTdmNDhmMDc2ZBoIaHJ2aG81MW0%3D
[16]	SODA K J, SLICE D E, NAYLOR G J P. Artifical neural networks and geometric morphometric methods as a means for classification: a case study using teeth from Carcharhinus[J]. J Morphology, 2017, 278(1): 131-141. http://www.ncbi.nlm.nih.gov/pubmed/27892600
[17]	YDENS E, PALMERS I, HENDRIX S, et al. The next generation of biomarker research in spinal cord injury[J]. Molecular Neurobiol, 2016, 54(2): 1-18. http://doclib.uhasselt.be/dspace/retrieve/22272/20160120%20Review_Ydens%20et%20al_revision.pdf
[18]	STEFANOVIC B, DURIC O, STANKOVIC S, et al. Elevated serum protein S100B and neuron specific enolase values as predictors of early neurological outcome after traumatic brain injury[J]. J Med Biochemi, 2017, 36(4): 314-321. http://www.dmbj.org.rs/jmb/pdf/2017-4/4.pdf
[19]	茅利明, 单平囡. NSE在外科病人血清中值的异常变化及意义探讨[J]. 浙江创伤外科, 2018, 23(2): 221-223. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJCW201802006.htm
[20]	张斌, 何惟高, 戴伶伶. 不同GCS评分脑挫伤患者额叶功能及血清及脑脊液NSE、MBP检测分析[J]. 浙江创伤外科, 2019, 24(1): 178-179. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJCW201901090.htm